InvestorsHub Logo
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

Re: None

Tuesday, 02/21/2017 3:52:45 PM

Tuesday, February 21, 2017 3:52:45 PM

Post# of 10580
In $KAST , we are dealing with a tiny float play in the biotech space. The company has a new deal in formation with a top-tier player to fund and attack areas in the biopharma space that offer the best ROI upon approach. This is every bit the nimble opportunist. That’s a plus for investors. http://www.stockonhighalert.com/newsletters/kast-offers-tactical-opportunity-strong-biopharma-trend/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.